Improve swallowing safety and function
- Trial ID
- NCT07153692
- Official Title
- Clinical Efficacy and Mechanism of tDCS for Dysphagia in Patients With Parkinson's Disease
- Goal
- Improve swallowing safety and function
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Wang Ping
- Study Type
- INTERVENTIONAL
- Enrollment
- 58 participants
- Conditions
- Parkinson's Disease and Parkinsonism, Dysphagia
- Interventions
- tDCS, Conventional Dysphagia Treatment, sham tDCS
Plain-Language Summary
The goal is to improve swallowing safety and function in people with Parkinson's disease or related disorders, lowering the risk of choking and aspiration. The approach uses transcranial direct current stimulation, a low, noninvasive electrical current applied over the brain areas that control swallowing to boost cortical excitability and plasticity, given alongside standard dysphagia therapy and compared with a sham stimulation. They are looking for adults 18 to 100 with VFSS-confirmed dysphagia and a diagnosis of Parkinson's, MSA, or PSP, who are cognitively intact (MMSE >23), can consent and cooperate, and do not have other causes of dysphagia, active pneumonia, severe organ failure, or metal implants.
Locations
- Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Frequently Asked Questions
- What is this trial testing?
- This trial is studying tDCS. The goal is to improve swallowing safety and function in people with Parkinson's disease or related disorders, lowering the risk of choking and aspiration. The approach uses transcranial direct current stimulation, a low, noninvasive electrical current applied over the brain areas that control swallowing to boost cortical excitability and plasticity, given alongside standard dysphagia therapy and compared with a sham stimulation. They are looking for adults 18 to 100 with VFSS-confirmed dysphagia and a diagnosis of Parkinson's, MSA, or PSP, who are cognitively intact (MMSE >23), can consent and cooperate, and do not have other causes of dysphagia, active pneumonia, severe organ failure, or metal implants.
- Who can participate?
- Participants must be between 18 Years and 100 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 4 years and 5 months.